BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16311757)

  • 1. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.
    Mosconi L; De Santi S; Li Y; Li J; Zhan J; Tsui WH; Boppana M; Pupi A; de Leon MJ
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):210-21. PubMed ID: 16311757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.
    Mosconi L; Tsui WH; De Santi S; Li J; Rusinek H; Convit A; Li Y; Boppana M; de Leon MJ
    Neurology; 2005 Jun; 64(11):1860-7. PubMed ID: 15955934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer's Disease in Mild Cognitive Impairment.
    Kang JM; Lee JY; Kim YK; Sohn BK; Byun MS; Choi JE; Son SK; Im HJ; Lee JH; Ryu YH; Lee DY
    Mol Diagn Ther; 2018 Aug; 22(4):475-483. PubMed ID: 29761365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.
    Huang SH; Hsiao WC; Chang HI; Ma MC; Hsu SW; Lee CC; Chen HJ; Lin CH; Huang CW; Chang CC
    BMC Med Imaging; 2024 Mar; 24(1):75. PubMed ID: 38549082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Li Y; Rinne JO; Mosconi L; Pirraglia E; Rusinek H; DeSanti S; Kemppainen N; Någren K; Kim BC; Tsui W; de Leon MJ
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2169-81. PubMed ID: 18566819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
    PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease.
    Uotani C; Sugimori K; Kobayashi K
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):319-26. PubMed ID: 16732748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
    Furukawa K; Okamura N; Tashiro M; Waragai M; Furumoto S; Iwata R; Yanai K; Kudo Y; Arai H
    J Neurol; 2010 May; 257(5):721-7. PubMed ID: 19946781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease.
    Willette AA; Modanlo N; Kapogiannis D;
    Diabetes; 2015 Jun; 64(6):1933-40. PubMed ID: 25576061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis.
    Clerici F; Del Sole A; Chiti A; Maggiore L; Lecchi M; Pomati S; Mosconi L; Lucignani G; Mariani C
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):646-57. PubMed ID: 20016455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
    Yun HJ; Kwak K; Lee JM;
    PLoS One; 2015; 10(6):e0129250. PubMed ID: 26061669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease.
    Westman E; Cavallin L; Muehlboeck JS; Zhang Y; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Simmons A; Wahlund LO;
    PLoS One; 2011; 6(7):e22506. PubMed ID: 21811624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the diagnostic accuracy of medial temporal lobe atrophy in Alzheimer's disease.
    Jacobs HI; Van Boxtel MP; van der Elst W; Burgmans S; Smeets F; Gronenschild EH; Verhey FR; Uylings HB; Jolles J
    J Alzheimers Dis; 2011; 25(3):477-90. PubMed ID: 21471642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal classification of Alzheimer's disease and mild cognitive impairment.
    Zhang D; Wang Y; Zhou L; Yuan H; Shen D;
    Neuroimage; 2011 Apr; 55(3):856-67. PubMed ID: 21236349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of normal aging, MCI and AD with multimodal imaging measures on the medial temporal lobe.
    Jhoo JH; Lee DY; Choo IH; Seo EH; Oh JS; Lee JS; Lee DS; Kim SG; Youn JC; Kim KW; Woo JI
    Psychiatry Res; 2010 Sep; 183(3):237-43. PubMed ID: 20705437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.